Kora Corporation Limited sell "Magnaspartate"

Magnaspartate is a prescription-only 243 mg powder-for-oral-solution form of magnesium aspartate dihydrate, used to treat magnesium deficiency (hypomagnesaemia), a condition affecting 60-65% of intensive-care patients given magnesium's role as a cofactor for over 300 enzymes in energy metabolism and biosynthesis. It is more water-soluble than other magnesium salts, a trait linked to better absorption, is well tolerated with no reported increase in stoma output, and its 10 mmol sachets dissolve in as little as 50 mL of water, tea, or orange juice, making it suitable for administration via gastric, duodenal, or nasal feeding tubes.